Japan Intellectual Property Rights: SERINE PALMITOYLTRANSFERASE (SPT) MRNA EXPRESSION PROMOTER, AQUAPORIN 3 (AQP3) MRNA EXPRESSION PROMOTER, CLAUDIN-1 MRNA EXPRESSION PROMOTER, CLAUDIN-4 MRNA EXPRESSION PROMOTER, AND OCCLUDIN MRNA EXPRESSION PROMOTER

Japan, Nov. 17 -- MARUZEN PHARMACEUT CO LTD has got intellectual property rights for 'SERINE PALMITOYLTRANSFERASE (SPT) MRNA EXPRESSION PROMOTER, AQUAPORIN 3 (AQP3) MRNA EXPRESSION PROMOTER, CLAUDIN-1 MRNA EXPRESSION PROMOTER, CLAUDIN-4 MRNA EXPRESSION PROMOTER, AND OCCLUDIN MRNA EXPRESSION PROMOTER.' Other related details are as follows:

Application Number: JP,2024-132445

Category (FI): A61K8/49,A61K31/19,A61K31/191,A61K31/194,A61K31/198,A61K31/205,A61K31/455,A61K31/513,A61K31/7012,A61K31/7068,A61K8/365,A61K8/44,A61K8/60,A61K8/67,A61P17/00,A61P17/16,A61P43/00,107,A61Q19/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Aug. 8, 2024

Publication Date: Oct. 11, 2024

The original document can be viewed at...